This is because the company is scaling up its European manufacturing capacity – a move that will impact the vaccine’s production for a “short period.”
“This expansion work means that Pfizer is temporarily reducing deliveries to all countries receiving vaccine manufactured at its European facility – and that includes Canada,” said Anand.
She said, however, that this won’t impact Canada’s long-term vaccination timeline.
“This is a temporary delay and we remain on track to have enough approved vaccines for everyone who wishes to be vaccinated by the end of September 2021,” Anand said.
More to come…
© 2021 Global News, a division of Corus Entertainment Inc.